HCA Healthcare Statistics
Share Statistics
HCA Healthcare has 253.30M shares outstanding. The number of shares has increased by -3.58% in one year.
Shares Outstanding | 253.30M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -1.47% |
Owned by Institutions (%) | n/a |
Shares Floating | 181.00M |
Failed to Deliver (FTD) Shares | 2.63K |
FTD / Avg. Volume | 0.19% |
Short Selling Information
The latest short interest is 2.60M, so 1.02% of the outstanding shares have been sold short.
Short Interest | 2.60M |
Short % of Shares Out | 1.02% |
Short % of Float | 1.42% |
Short Ratio (days to cover) | 1.89 |
Valuation Ratios
The PE ratio is 14.07 and the forward PE ratio is 14.28. HCA Healthcare 's PEG ratio is 0.4.
PE Ratio | 14.07 |
Forward PE | 14.28 |
PS Ratio | 1.13 |
Forward PS | 1.1 |
PB Ratio | -41.56 |
P/FCF Ratio | 15.73 |
PEG Ratio | 0.4 |
Enterprise Valuation
HCA Healthcare Inc. has an Enterprise Value (EV) of 114.66B.
EV / Earnings | 21.87 |
EV / Sales | 1.76 |
EV / EBITDA | 9.01 |
EV / EBIT | 11.91 |
EV / FCF | 24.46 |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of -22.01.
Current Ratio | 1.18 |
Quick Ratio | 1.02 |
Debt / Equity | -22.01 |
Total Debt / Capitalization | 104.76 |
Cash Flow / Debt | 0.24 |
Interest Coverage | 4.97 |
Financial Efficiency
Return on equity (ROE) is -2.95% and return on capital (ROIC) is 17.73%.
Return on Equity (ROE) | -2.95% |
Return on Assets (ROA) | 0.09% |
Return on Capital (ROIC) | 17.73% |
Revenue Per Employee | 295.31K |
Profits Per Employee | 23.83K |
Employee Count | 220.00K |
Asset Turnover | 1.16 |
Inventory Turnover | 27.38 |
Taxes
Income Tax | 1.61B |
Effective Tax Rate | 0.21 |
Stock Price Statistics
The stock price has increased by 16.14% in the last 52 weeks. The beta is 1.69, so HCA Healthcare 's price volatility has been higher than the market average.
Beta | 1.69 |
52-Week Price Change | 16.14% |
50-Day Moving Average | 358.28 |
200-Day Moving Average | 347.15 |
Relative Strength Index (RSI) | 21.67 |
Average Volume (20 Days) | 1.40M |
Income Statement
In the last 12 months, HCA Healthcare had revenue of $64.97B and earned $5.24B in profits. Earnings per share was $19.24.
Revenue | 64.97B |
Gross Profit | 9.63B |
Operating Income | 9.63B |
Net Income | 5.24B |
EBITDA | 12.72B |
EBIT | 9.63B |
Earnings Per Share (EPS) | 19.24 |
Balance Sheet
The company has $935.00M in cash and $41.86B in debt, giving a net cash position of -$40.92B.
Cash & Cash Equivalents | 935.00M |
Total Debt | 41.86B |
Net Cash | -40.92B |
Retained Earnings | -1.35B |
Total Assets | 59.46B |
Working Capital | 1.76B |
Cash Flow
In the last 12 months, operating cash flow was $9.43B and capital expenditures -$4.74B, giving a free cash flow of $4.69B.
Operating Cash Flow | 9.43B |
Capital Expenditures | -4.74B |
Free Cash Flow | 4.69B |
FCF Per Share | 17.21 |
Margins
Gross margin is 14.82%, with operating and profit margins of 14.82% and 8.07%.
Gross Margin | 14.82% |
Operating Margin | 14.82% |
Pretax Margin | 11.86% |
Profit Margin | 8.07% |
EBITDA Margin | 19.58% |
EBIT Margin | 14.82% |
FCF Margin | 7.21% |
Dividends & Yields
HCA pays an annual dividend of $2.64, which amounts to a dividend yield of 0.85%.
Dividend Per Share | $2.64 |
Dividend Yield | 0.85% |
Dividend Growth (YoY) | 10% |
Payout Ratio | 11.85% |
Earnings Yield | 6.13% |
FCF Yield | 5.89% |
Analyst Forecast
The average price target for HCA is $400, which is 27.4% higher than the current price. The consensus rating is "Buy".
Price Target | $400 |
Price Target Difference | 27.4% |
Analyst Consensus | Buy |
Analyst Count | 15 |
Scores
Altman Z-Score | 2.57 |
Piotroski F-Score | 6 |